Effect on the healing of periapical perforations in dogs of the addition of growth factors to calcium hydroxide.
The purpose of this study was to investigate the effect of the addition of platelet-derived growth factor-BB and insulin-like growth factor-I to calcium hydroxide in the repair of apical perforations in dogs. Fifty-one premolar teeth of four beagle dogs were used. After developing periapical lesions root apices were artificially perforated. The teeth were divided into the three groups: group 1, the apical perforations were not sealed; group 2, the perforated areas were obturated with calcium hydroxide; and group 3, calcium hydroxide plus growth factors was applied to the sites of perforation. All canals were filled by a lateral condensation technique. Animals were killed 12 wk later, and sections were hematoxylin & eosin-stained and immunostained for osteonectin. The amount of inflammation was evaluated histomorphologically. The one-way ANOVA test demonstrated that the three groups were significantly different from one another. In group 3 there was no inflammatory reaction of apical tissue, and the connective tissue adjacent to the newly formed hard tissue was strongly immunostained for osteonectin. Most sections in group 1 showed no apical healing. Moderate healing was found in group 2. In conclusion the combination of platelet-derived growth factor-BB and insulin-like growth factor-I with calcium hydroxide improved healing of apical perforation in dogs.
Kim
M
M
Department of Conservative Dentistry, Asan Medical Center, Seoul, Korea.
Kim
B
B
Yoon
S
S
D016301:Alveolar Bone Loss / Q000188:drug therapy / Q000209:etiology; D000704:Analysis of Variance; D000818:Animals; D000077214:Becaplermin; D002126:Calcium Hydroxide / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D004285:Dogs; D004338:Drug Combinations; D007150:Immunohistochemistry; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology* / Q000627:therapeutic use; D015676:Osteonectin / Q000502:physiology; D010482:Periapical Abscess / Q000188:drug therapy / Q000209:etiology; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology* / Q000627:therapeutic use; D020574:Proto-Oncogene Proteins c-sis; D012388:Root Canal Irrigants / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D018915:Root Canal Preparation / Q000009:adverse effects; D019227:Tooth Apex / Q000293:injuries*; D014945:Wound Healing / Q000187:drug effects*
D004338:Drug Combinations; D015676:Osteonectin; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D012388:Root Canal Irrigants; D000077214:Becaplermin; D007334:Insulin-Like Growth Factor I; D002126:Calcium Hydroxide